LambdaVision secured $7M in seed funding to scale its in-space manufacturing process for protein-based artificial retinas. The team has flown nine ISS missions and demonstrated 200-layer thin-film assembly in orbit, supported by a NASA Phase 2 ISPA award. The new capital funds operations through 2027 as the company pushes toward clinical-trial preparation. Seven Seven Six and Aurelia Foundry Fund led the round.
- Company
- LambdaVision lambdavision.com
- Round
- Seed
- Amount
- $7M
- Source
- payloadspace.com
- In the newsletter
- No. 218, Manufacturing’s Missing ChatGPT Moment